¡¶PNAS¡·ºÃÏûÏ¢£¿¸ÐÈ¾ÖØÖ¢COVID-19ÖúÓÚÔ¤·ÀHIV
Èðµä¿¨ÂÞÁÕ˹¿¨Ñо¿ËùºÍµÂ¹úÂí¿Ë˹¡¤ÆÕÀʿ˽ø»¯ÈËÀàѧÑо¿ËùÔÚpNASÆÚ¿¯ÉÏ·¢±íµÄÒ»ÏîÐÂÑо¿µÃ³ö½áÂÛ£ºÐ¹ڲ¡¶¾ÒÅ´«±äÒìÓÉÄá°²µÂÌØÈËÒÅ´«¶øÀ´£¬µ«ÕâÖÖ±äÒìÓëHIV¸ÐȾ·çÏÕ½µµÍ£¨27%£©Óйء£
һЩÈËÔÚ¸ÐȾSARS-CoV-2¹Ú×´²¡¶¾Ê±»á»¼Öز¡£¬¶øÁíһЩÈËÖ»ÓÐÇá΢֢״»ò¸ù±¾Ã»ÓÐÖ¢×´¡£³ýÁËÖîÈçÀÏÄêCOVID-19µÈ¸ßΣÒòËØ£¬ÈçÌÇÄò²¡£¬ÎÒÃǵÄÒÅ´«ÒŲú£¨»ùÒò£©Ò²ÓÐÖúÓÚÎÒÃǵĸöÈËCOVID-19ÑÏÖØÐÔ·çÏÕ¡£
2020Çï¼¾£¬¿¨ÂÞÁÖ˹¿¨Ñ§ÔºµÄHugo ZebergºÍÂí¿Ë˹ÆÕÀʿ˽ø»¯ÈËÀàѧÑо¿ËùºÍ˹ÍòÌØ¡¤p¡¤Ë¹²¨²©·¢ÏÖ£¬ÎÒÃÇ´ÓÄá°²µÂÌØÈËÒÅ´«ÁËÑÏÖØµÄCOVID-19ÒÅ´«·çÏÕÒò×Ó¡£ÔÚ2021´º¼¾£¬Í¬Ò»Ñо¿ÕßDuoÑо¿ÁËÈËÀàDNAÖеÄÕâÖÖ±äÒ죬²¢¹Û²ìµ½×Ô´ÓÉÏÒ»¸ö±ùºÓʱ´úÒÔÀ´£¬ËüµÄƵÂÊÏÔÖøÔö¼Ó¡£ÊÂʵÉÏ£¬´ÓÄá°²µÂÌØÈËÉíÉÏÒÅ´«ÏÂÀ´µÄÒ»ÖÖ»ùÒò±äÒìÒѾ³öÈËÒâÁÏµØÆÕ±é´æÔÚ¡£
¡°SARS-CoV-2µÄÖ÷ÒªÒÅ´«Î£ÏÕÒòËØÊÇÈç´ËÆÕ±é£¬ÒÔÖÁÓÚÎÒ¿ªÊ¼»³ÒÉËüÊÇ·ñÕæµÄ¶ÔijЩ¶«Î÷Óкô¦£¬±ÈÈçÌṩ±£»¤£¬·ÀÖ¹ÁíÒ»ÖÖ´«È¾²¡¡£¡±pNAS×îÐÂÑо¿µÄΨһ×÷ÕßHugo Zeberg˵¡£
HIVÊÜÌå¼õÉÙ
ÒÅ´«·çÏÕÒò×ÓλÓÚ3ºÅȾɫÌåÉÏÓÉÐí¶à»ùÒò×é³ÉµÄÇøÓò¡£Ëü¸½½üÓм¸¸ö»ùÒò±àÂëÃâÒßϵͳÖеÄÊÜÌå¡£ÆäÖÐÒ»ÖÖÊÜÌ塪¡ªCCR5¡ª¡ª±»HIV²¡¶¾ÓÃÀ´¸ÐȾ°×ϸ°û¡£
Zeberg·¢ÏÖЯ´øCOVID-19²¡¶¾µÄÈËCCR5ÊÜÌå½ÏÉÙ¡£ÕâÈÃËû²âÊÔÁËËûÃÇÊÇ·ñÒ²Óнϵ͵ĸÐȾ°¬×̲¡¶¾µÄ·çÏÕ¡£Í¨¹ý·ÖÎöÈýÖÖÖ÷ÒªÉúÎï¿â£¨FiNGEN£¬Ó¢¹úBiBoandºÍÃÜЪ¸ù»ùÒò×鼯»®£©µÄCOVID-19µÄ±äÒìЯ´øÕß»¼ÕßÊý¾Ý£¬×÷Õß·¢ÏÖËûÃǸÐȾHIVµÄ·çÏÕ½µµÍÁË27%¡£
Zeberg˵£º¡°Èç¹ûÒ»¸öÈ˸ÐȾCOVID-19£¬ÄÇôÀֹ۵㣬ºÃÏûÏ¢ÊÇËü¿ÉÒÔÔ¤·ÀHIV¸ÐȾ¡£¡±
ÁíÒ»ÖÖ½âÊÍ
µ¼ÖÂCOVID-19±äÒì¸ÐȾµÄ»ùÒò±äÒìÔÚ10000Äêǰ¾ÍÔÚÈËÀàÖÐÆÕ±é´æÔÚÁË£¬µ«ÊÇHIVÔÚ21ÊÀ¼Í²Å³öÏÖ£¬ÕâÓÖÊÇÒ»¸öÃÔ¡£
Zeberg½âÊ͵À£¬ÏÖÔÚÎÒÃÇÖªµÀCOVID-19µÄÒÅ´«·çÏÕ¿ÉÒÔÔ¤·ÀHIVµÄ·¢Éú£¬µ«ËüÔÚÉÏÒ»¸ö±ùºÓʱ´úÖ®ºó£¬Ò²¿ÉÄܵÖÓùÁíÒ»ÖÖ¼²²¡£¬¸Ã¼²²¡µÄƵÂÊÔÚÄǸöʱÆÚÔö¼ÓÁË¡£
¡°The major genetic risk factor for severe COVID-19 associated with protection against HIV¡±. Hugo Zeberg. proceedings of the National Academy of Sciences (pNAS), online 21 February 2022, doi: 10.1073/pnas.2116435119.